Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

8.910 -0.270 (-2.94%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
60 61 Next >
Earnings Outlook For Novavax
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories
Benzinga 
Via Benzinga
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
The European Union bloc is reportedly negotiating an amended deal with Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) for around 70 million COVID-19 vaccine doses, despite the European public... 
Via Benzinga
2 Popular Stocks to Avoid in April and Beyond
These two "pandemic stocks" aren't worth investing in. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge
Novavax and Vaxart have each dropped more than 80% over the past year. 
Via The Motley Fool
7 Short-Squeeze Stocks That Are Breaking All the Rules
Although the bears have every reason to cynically target these troubled enterprises, they vexingly represent short-squeeze stocks. 
Via InvestorPlace
Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't?
The company is facing a litigation headwind and continued competition. 
Via Investor's Business Daily
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market... 
Via Benzinga
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?
Moderna's pain translates to Novavax's gain. 
Via The Motley Fool
3 Former High-Flying Stocks Down 92% to 99% That Billionaire Investors Can't Stop Buying
Despite losing most of their value, these former Wall Street darlings have been popular buys among billionaire money managers. 
Via The Motley Fool
AMC Entertainment Is Most Expensive Stock For Short Sellers, But What Other Stocks Top The List?
With its persistent net losses, a recent reverse stock split, massive shareholder dilution and nearly $5 billion in debt, AMC Entertainment Holdings Inc (NYSE: AMC) may seem like an obvious candidate... 
Via Benzinga
7 Short-Squeeze Stocks That Are Driving Hedge Funds Crazy
Although market bears seem to have the right idea with these short-squeeze stocks, the bulls continue to frustrate them. 
Via InvestorPlace
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards. 
Via InvestorPlace
Stop! Don’t Infect Your Portfolio With Toxic Novavax Stock.
Novavax used those two dreaded words - "going concern" - and that's a signal for sensible investors to stay away from NVAX stock. 
Via InvestorPlace
FTX's Native Token Might Be Relaunched, Putin Personally Approved Arrest Of American Journalist Evan Gershkovich, Fox News-Dominion Voting Systems Trial To Start Monday: Today's Top Stories
Benzinga 
Via Benzinga
Novavax Plans to Cut $50 Million in Costs, COVID-19 Vaccine Remains Only Marketed Product
Novavax Inc's (NASDAQ: NVAX) CEO, newly appointed CEO John Jacobs, said the company would cut about $50 million in costs in Q1 of 2023 and plans further cuts. 
Via Benzinga
Novavax Outlook: Why NVAX Stock Could 12X in the Next 12 Months
Recent, positive clinical data released by Novavax (NVAX) indicates that NVAX stock could surge almost 12 times in the next year. 
Via InvestorPlace
March CPI 2023: The Numbers That All Investors Are Watching Today
The March CPI data is out and there are a few key numbers that investors will want to keep in mind while trading on Wednesday. 
Via InvestorPlace
Why Is Novavax (NVAX) Stock Moving Today?
Novavax (NVAX) stock is on the move Wednesday despite a lack of news from the vaccine company and no heavy trading volume. 
Via InvestorPlace
Why Novavax Stock Is Seeing Blue Skies
Novavax Inc (NASDAQ: NVAX) shares are trading higher by 9.88% to $8.34 Thursday afternoon. The stock may be reacting to the company's presentations at the 2023 World Vaccine Congress this week. 
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
1 Stock to Buy and 1 to Avoid Before the Next Bull Market
These stocks could move in opposite directions come the next bull market. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 ‘Fallen Angel’ Stocks to Sell Before They Plummet Again
These seven stocks to sell have already become out of favor among investors, but that doesn't mean they can't sink further from here. 
Via InvestorPlace
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates of hospitalizations and COVID remains many... 
Via Benzinga
1 Growth Stock With 741% Upside, According to Wall Street
The vaccine maker has delivered returns of this size before, but things have changed a lot since. 
Via The Motley Fool
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
60 61 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.